Recommendations on the Selection, Development, and Modification of Performance Outcome Assessments: A Good Practices Report of an ISPOR Task Force

Jul 1, 2023, 00:00 AM
10.1016/j.jval.2023.05.003
https://www.valueinhealthjournal.com/article/S1098-3015(23)02598-6/fulltext
Section Title : ISPOR REPORT
Section Order : 959
First Page : 959

In evaluating the clinical benefit of new therapeutic interventions, it is critical that the treatment outcomes assessed reflect aspects of health that are clinically important and meaningful to patients. Performance outcome (PerfO) assessments are measurements based on standardized tasks actively undertaken by a patient that reflect physical, cognitive, sensory, and other functional skills that bring meaning to people’s lives. PerfO assessments can have substantial value as drug development tools when the concepts of interest being measured best suit task performance and in cases where patients may be limited in their capacity for self-report. In their development, selection, and modification, including the evaluation and documentation of validity, reliability, usability, and interpretability, the good practice recommendations established for other clinical outcome assessment types should continue to be followed, with concept elicitation as a critical foundation. In addition, the importance of standardization, and the need to ensure feasibility and safety, as well as their utility in patient groups, such as pediatric populations, or those with cognitive and psychiatric challenges, may enhance the need for structured pilot evaluations, additional cognitive interviewing, and evaluation of quantitative data, such as that which would support concept confirmation or provide ecological evidence and other forms of construct evidence within a unitary approach to validity. The opportunity for PerfO assessments to inform key areas of clinical benefit is substantial and establishing good practices in their selection or development, validation, and implementation, as well as how they reflect meaningful aspects of health is critical to ensuring high standards and in furthering patient-focused drug development.

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02598-6&doi=10.1016/j.jval.2023.05.003
HEOR Topics :
  • Best Research Practices
  • Clinical Outcomes
  • Instrument Development, Validation, & Translation
  • Methodological & Statistical Research
  • Organizational Practices
  • Patient-Centered Research
  • Performance-based Outcomes
  • PRO & Related Methods
Tags :
  • patient focused drug development
  • PerfO assessment
  • performance outcome assessment
  • task performance
Regions :
  • Global